China NT Pharma Group Company Limited (HKG:1011)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.4200
+0.0200 (5.00%)
Jun 30, 2025, 1:54 PM HKT

HKG:1011 Statistics

Total Valuation

HKG:1011 has a market cap or net worth of HKD 283.18 million. The enterprise value is 673.02 million.

Market Cap 283.18M
Enterprise Value 673.02M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date Aug 29, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:1011 has 674.25 million shares outstanding. The number of shares has increased by 27.18% in one year.

Current Share Class 674.25M
Shares Outstanding 674.25M
Shares Change (YoY) +27.18%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 36.84%
Owned by Institutions (%) n/a
Float 121.93M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.01
PB Ratio -0.67
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -11.85
EV / Sales 16.66
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -68.42

Financial Position

The company has a current ratio of 0.02

Current Ratio 0.02
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -40.67
Interest Coverage -0.42

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -2.49%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 3.38%
Revenue Per Employee 1.84M
Profits Per Employee -2.58M
Employee Count 22
Asset Turnover 0.11
Inventory Turnover n/a

Taxes

Income Tax -130,893
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +14.29% in the last 52 weeks. The beta is -1.76, so HKG:1011's price volatility has been lower than the market average.

Beta (5Y) -1.76
52-Week Price Change +14.29%
50-Day Moving Average 0.41
200-Day Moving Average 0.31
Relative Strength Index (RSI) 42.74
Average Volume (20 Days) 250,893

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:1011 had revenue of HKD 40.40 million and -56.78 million in losses. Loss per share was -0.22.

Revenue 40.40M
Gross Profit 5.60M
Operating Income -14.07M
Pretax Income -56.91M
Net Income -56.78M
EBITDA -14.02M
EBIT -14.07M
Loss Per Share -0.22
Full Income Statement

Balance Sheet

The company has 10.24 million in cash and 400.08 million in debt, giving a net cash position of -389.84 million or -0.58 per share.

Cash & Cash Equivalents 10.24M
Total Debt 400.08M
Net Cash -389.84M
Net Cash Per Share -0.58
Equity (Book Value) -424.72M
Book Value Per Share -1.61
Working Capital -754.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.65 million and capital expenditures -189,423, giving a free cash flow of -9.84 million.

Operating Cash Flow -9.65M
Capital Expenditures -189,423
Free Cash Flow -9.84M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 13.86%, with operating and profit margins of -34.84% and -140.56%.

Gross Margin 13.86%
Operating Margin -34.84%
Pretax Margin -140.89%
Profit Margin -140.56%
EBITDA Margin -34.72%
EBIT Margin -34.84%
FCF Margin n/a

Dividends & Yields

HKG:1011 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -27.18%
Shareholder Yield n/a
Earnings Yield -20.05%
FCF Yield -3.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 3, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date Jul 3, 2024
Split Type Reverse
Split Ratio 0.1

Scores

HKG:1011 has an Altman Z-Score of -13.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -13.18
Piotroski F-Score 1